Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Cigna Group (CI) stock in plain English

Free brief · no signupStart here
CIPublished Nov 13, 2026
Cigna Group
Healthcare · Healthcare Plans
Manages pharmacy benefits, coordinates specialty drug delivery, and administers commercial medical plans for employers and government programs.
Assets:
Express Scripts PBMprocesses over one billion prescriptions annually
Accredo Specialty Pharmacydispenses complex drugs for chronic conditions
Cigna Healthcareprovides medical coverage to millions of commercial members
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

53
OPS ScoreOperating finances
Latest quote
-4.32%$273.04
$71.95B
12.1×
$287.79B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was CI. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Cigna Group (CI) do?

Cigna Group (CI) is a U.S.-listed company in Healthcare (Healthcare Plans). What it does: Manages pharmacy benefits, coordinates specialty drug delivery, and administers commercial medical plans for employers and government programs. Pairs massive pharmacy benefit management and specialty drug distribution with employer health insurance plans. It is worth $71.95B on the market and sold $287.79B over the last year.

Market cap
$71.95B
P/E ratio
12.1×
Annual sales
$287.79B
Sector
Healthcare
Industry
Healthcare Plans
Brief updated
Nov 13, 2026

Brands and businesses behind CI

  • Express Scripts: It provides pharmacy benefit management services, earning fees by processing claims and negotiating volume discounts on prescription drugs.
  • Evernorth Health Services: It delivers coordinated health solutions and clinical care programs, generating revenue through enterprise contracts with health plans and employers.
  • Accredo: It dispenses expensive medications for rare diseases, generating revenue from direct specialty pharmaceutical sales and patient support services.
  • MDLIVE: It offers virtual medical and behavioral consultations, earning fees per telehealth visit from employers and insurers.
  • CuraScript SD: It distributes specialty drugs to healthcare providers, generating sales revenue from medical practices, clinics, and hospital systems.

CI’s flags, in plain English

Each flag is a number from Cigna Group’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Cheap on Cash Flow

Priced at 8.7 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Still Climbing

Sales up 11.4% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Bargain or Trap?

Priced at 12.1 times its yearly profit, on the cheap side. The stock trades cheaper than it usually does. A low price can hide a real problem, so read the risks.

Runway Is Short

This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about CI

How big is Cigna Group?

Cigna Group’s market cap is $71.95B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $287.79B: what customers paid the company over the last year, before any costs.

What is CI’s P/E ratio?

CI’s P/E ratio is 12.1×. Investors pay about 12.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with CI?

Federal and state regulators are investigating pharmacy benefit managers over drug pricing practices and transparency. That is one risk on Cigna Group’s card. Its first risk flag is Runway Is Short, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Cigna Group’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CI’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card